1. Home
  2. TATT vs TRDA Comparison

TATT vs TRDA Comparison

Compare TATT & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TAT Technologies Ltd.

TATT

TAT Technologies Ltd.

HOLD

Current Price

$37.49

Market Cap

522.1M

Sector

Industrials

ML Signal

HOLD

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$13.73

Market Cap

481.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TATT
TRDA
Founded
1985
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
522.1M
481.6M
IPO Year
2002
2021

Fundamental Metrics

Financial Performance
Metric
TATT
TRDA
Price
$37.49
$13.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
3
Target Price
$57.17
$21.00
AVG Volume (30 Days)
196.2K
151.1K
Earning Date
05-18-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$25,421,000.00
Revenue This Year
$16.29
$39.97
Revenue Next Year
$16.09
$50.80
P/E Ratio
$38.61
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.56
$4.93
52 Week High
$64.50
$14.49

Technical Indicators

Market Signals
Indicator
TATT
TRDA
Relative Strength Index (RSI) 33.97 55.94
Support Level $34.39 $10.84
Resistance Level $41.44 $13.99
Average True Range (ATR) 2.45 0.70
MACD -0.00 0.00
Stochastic Oscillator 0.89 67.23

Price Performance

Historical Comparison
TATT
TRDA

About TATT TAT Technologies Ltd.

TAT Technologies Ltd provides solutions and services to the commercial and military aerospace and ground defense industries, focused mainly on three product areas and services: Thermal Management, Power and Actuation, and Maintenance, Repair and Overhaul (MRO). Its product portfolio includes heat exchangers, cooling systems, and mechanical aircraft accessories and systems such as pumps, valves, and turbine power units. Its operating segments are MRO services for aviation components, which derive key revenue, Original equipment manufacturing (OEM) of heat transfer solutions and aviation accessories, MRO services for heat transfer components and OEM of heat transfer solutions, and Overhaul and coating of jet engine components. Geographically, it derives key revenue from the United States.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Share on Social Networks: